Clinical Trial Update: Phase II Study of GTx024 in Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II study of GTx024 in women with metastatic breast cancer was terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• GTx024

Snippet

Sponsor: GTx | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-03-08